ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG

Ask a doctor about a prescription for ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG

5.0(3)

Ngozi Precious Okwuosa

General medicine6 years of experience

Dr. Ngozi Precious Okwuosa is a Primary Care Physician with over 5 years of clinical experience in Hungary, Sweden, and Nigeria. A graduate of the University of Szeged (cum laude), she offers online consultations for adults in the areas of internal medicine, women’s health, and postoperative care.

Key areas of consultation:

Preventive and family medicine
Women’s health, including gynaecology and obstetrics
Chronic disease management: hypertension, diabetes, and more
Mental health support, anxiety, and counselling
Postoperative care and lab test interpretation

She has conducted research on the genetic background of stroke and is skilled in communicating with patients from diverse cultural backgrounds. Her approach combines clinical expertise with empathy and clear communication.

Book a video appointment

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Book a video appointment

Ngozi Precious Okwuosa

General medicine6 years of experience

Key areas of consultation:

Preventive and family medicine
Women’s health, including gynaecology and obstetrics
Chronic disease management: hypertension, diabetes, and more
Mental health support, anxiety, and counselling
Postoperative care and lab test interpretation

Book a video appointment

Tomasz Grzelewski

Dermatology21 years of experience

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Book a video appointment

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG

Introduction

Package Leaflet: Information for the User

Icatibant Aguettant 30 mg solution for injection in pre-filled syringe EFG

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Keep this leaflet, you may need to read it again. If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

What is Icatibant Aguettant and what is it used for
What you need to know before you use Icatibant Aguettant
How to use Icatibant Aguettant
Possible side effects
Storage of Icatibant Aguettant
Contents of the pack and other information

1. What is Icatibant Aguettant and what is it used for

This medicine contains the active substance icatibant.

Icatibant is used to treat acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older.

In HAE, the levels of a substance present in the blood called bradykinin increase, producing symptoms such as swelling, pain, nausea and diarrhoea.

Icatibant blocks the action of bradykinin and thus reduces the progression of symptoms of an HAE attack.

2. What you need to know before you use Icatibant Aguettant

N

if you are allergic to icatibant or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor before starting icatibant treatment:

If you have coronary heart disease (reduced blood flow to the heart).
If you have recently had a stroke.

The side effects related to icatibant are similar to the symptoms of your own illness. Consult your doctor immediately if you notice that the symptoms of the attack worsen after icatibant administration.

In addition:

You or your caregiver should learn the technique for subcutaneous injections (under the skin) before self-administering or having icatibant administered by your caregiver.
Immediately after self-administering icatibant or having it administered by your caregiver while experiencing a laryngeal attack (upper airway obstruction), you should seek medical attention at a medical institution.
If your symptoms do not resolve after a self-administered injection of icatibant or an injection administered by your caregiver, you should consult your doctor about the administration of additional icatibant injections. In adult patients, up to 2 additional injections can be administered within 24 hours.

N

Icatibant is not recommended for use in children under 2 years of age or weighing less than 12 kg because it has not been studied in these patients.

O

Tell your doctor if you are taking, have recently taken or might take any other medicines.

No interactions of icatibant with other medicines are known. If you are taking any medicine that is an angiotensin-converting enzyme inhibitor (ACEI) (e.g. captopril, enalapril, ramipril, quinapril, lisinopril) to reduce blood pressure or for any other reason, inform your doctor before using icatibant.

E

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

If you are breastfeeding, you should not breastfeed your child during the 12 hours following the last administration of icatibant.

C

Do not drive or use machines if you feel tired or dizzy as a result of the HAE attack or after using icatibant.

I

This medicine contains less than 23 milligrams (1 mmol) of sodium per syringe, and is therefore essentially ‘sodium-free’.

3. How to use Icatibant Aguettant

Follow the instructions for administration of this medicine exactly as told by your doctor. In case of doubt, consult your doctor again.

If you have never been administered icatibant before, the first dose should always be injected by medical or nursing staff. Your doctor will discharge you when he/she considers it safe for you to go home. After discussing with your doctor or nurse and learning the technique for subcutaneous injections (under the skin), you or your caregiver can administer icatibant if you have an HAE attack. It is important to inject icatibant subcutaneously (under the skin) as soon as you notice an angioedema attack. Healthcare professionals will teach you and your caregiver how to safely inject icatibant, following the instructions in the package leaflet.

C

Your doctor has determined the exact dose of icatibant and will tell you how often to use it.

A

The recommended dose of icatibant is one injection (3 ml, 30 mg) administered subcutaneously (under the skin) as soon as you notice an angioedema attack (e.g. with increased skin swelling, especially on the face and neck, or increased abdominal pain).

If you do not notice an improvement in symptoms after 6 hours, you should seek medical advice about the administration of additional icatibant injections. In adults, up to 2 additional injections can be administered within 24 hours.

-N.

Children and adolescents from 2 to 17 years

The recommended dose of icatibant is one injection of 1 ml up to a maximum of 3 ml based on body weight, administered subcutaneously (under the skin) as soon as symptoms of an angioedema attack appear (e.g. increased skin swelling, especially on the face and neck, or increased abdominal pain).

See the instructions for use section to determine the dose to be injected.

If you are unsure about the dose to be injected, consult your doctor, pharmacist or nurse.

-iyour symptoms worsen or do not improve, you should seek medical advice immediately.

How to administer Icatibant Aguettant

Icatibant is administered by subcutaneous injection (under the skin). Each syringe should only be used once.

Icatibant is injected with a short needle into the fatty tissue under the skin of the abdomen (belly). If you have any further questions on the use of this product, ask your doctor or pharmacist.

The following step-by-step instructions are intended for:

self-administration (adults)
administration by a caregiver or healthcare professional for adults, adolescents or children over 2 years (weighing at least 12 kg).

The instructions include the following main steps:

General information

2a) Preparation of the syringe for children and adolescents (2-17 years) weighing 65 kg or less 2b) Preparation of the syringe and needle for injection (all patients)

Preparation of the injection site
Injection of the solution
Disposal of injection materials

Step-by-step instructions for injection

General information

Clean the work surface area before starting the process.
Wash your hands with water and soap.
Open the tray by removing the seal.
Remove the pre-filled syringe from the tray.
Unscrew and remove the cap from the end of the pre-filled syringe.
Leave the pre-filled syringe with the cap unscrewed.

2a) Preparation of the syringe

for children and adolescents (2-17 years) weighing 65 kg or less:

Important information for healthcare professionals and caregivers:

When the dose is less than 30 mg (3 ml), the following equipment is needed to extract the correct dose (see information below):

Icatibant Aguettant pre-filled syringe (with icatibant solution)
Connector (adapter)
3 ml graduated syringe

Syringe with black plunger and graduated scale, next to a connector and another syringe without visible scale

The required injection volume in ml should be prepared in an empty 3 ml graduated syringe (see table below).

Table 1: Dosage schedule for children and adolescents

Body weight	Injection volume
12 kg to 25 kg	10 mg (1.0 ml)
26 kg to 40 kg	15 mg (1.5 ml)
41 kg to 50 kg	20 mg (2.0 ml)
51 kg to 65 kg	25 mg (2.5 ml)

Patients weighing more than 65 kgwill use the entire contents of the pre-filled syringe (3 ml).

If you are unsure about the volume of solution to be extracted, consult your doctor, pharmacist or nurse

Remove the caps from each end of the connector.

Avoid touching the ends of the connector and the tips of the syringes to prevent contamination

Screw the connector onto the pre-filled syringe.

Attach the graduated syringe to the other end of the connector, making sure that both connections fit securely.

Syringe disassembled with two main parts, transparent plunger with black marks and white cylinder with red rings

Transfer the icatibant solution to the graduated syringe:

To initiate the transfer of the icatibant solution, push the plunger of the pre-filled syringe (on the left end of the image below).

Transparent syringe with black plunger and numeric graduations, red arrows indicate direction of plunger movement

If the icatibant solution does not start to transfer to the graduated syringe, gently pull the plunger of the graduated syringe until the icatibant solution starts to flow into the graduated syringe (see image below).

Pre-filled syringe with black and white plunger, red arrow indicates direction of injection

Continue pushing the plunger of the pre-filled syringe until the required injection volume (dose) is transferred to the graduated syringe. See Table 1 for dosing information.

If there is air in the graduated syringe:

Turn the connected syringes so that the pre-filled syringe is on top (see image below).

Pre-filled syringe with dark liquid and retracted plunger, red arrow indicates direction of injection

Push the plunger of the graduated syringe to transfer the air back to the pre-filled syringe (this step may need to be repeated several times).

Extract the required volume of icatibant solution.

Remove the pre-filled syringe and connector from the graduated syringe.

Dispose of the pre-filled syringe and connector in the sharps container.

2b) Preparation of the syringe and needle for injection: All patients (adults, adolescents and children)

Hands holding an insulin applicator and a disposable needle preparing for injection

Remove the cap from the needle hub
Remove the seal from the needle cap (the needle should remain inside the cap)

Hand holding syringe with needle and inserting it into the skin, red arrow indicates direction of insertion

Hold the syringe firmly. Carefully attach the needle to the pre-filled syringe with the colorless solution.
Screw the pre-filled syringe onto the needle, still fixed in the cap
Pull the syringe to remove the needle from the cap. Do not pull the plunger.
The syringe is now ready to administer the injection

Preparation of the injection site

Abdomen with blue adhesive patch applied and schematic lines representing skin and underlying tissue layers

Choose the injection site. The injection site should be a fold of the abdomen, approximately 5-10 cm (2-4 inches) below the navel, to one side or the other. The area should be at least 5 cm (2 inches) away from any scar. Do not choose an area with bruises, inflammation or pain.
Clean the injection site by rubbing it with an alcohol swab and let it dry.

Injection of the solution

Syringe with needle pointing downwards held by a hand with red arrow indicating direction of injection

Hold the syringe between two fingers, with your thumb on the end of the plunger
Check that there is no air in the syringe by pressing the plunger until the first drop appears at the tip of the needle

Hand holding syringe injecting medication into abdomen with needle inserted into skin

Hold the syringe with the needle at an angle of 45 to 90 degrees to the skin
Holding the syringe in one hand, with the other hand gently take a fold of skin between your thumb and fingers at the previously cleaned site
Holding the skin fold, bring the syringe close and quickly insert the needle into the fold
Slowly press the plunger with a firm pulse, until all the fluid has been injected into the skin and no liquid remains in the syringe
Press slowly, so that the process takes approximately 30 seconds
Release the skin fold and gently remove the needle

Disposal of injection materials

Needle inserted into a vial stopper with a syringe connected and an arrow indicating direction of insertion

Discard the syringe, needle and its cap in the sharps container for disposal of sharp objects.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Almost all patients who receive icatibant notice a reaction at the injection site (such as skin irritation, inflammation, pain, itching, redness of the skin and burning). These effects are usually mild and improve without the need for any additional treatment.

Very common(may affect more than 1 in 10 people):

Additional reactions at the injection site (feeling of pressure, bruising, decreased sensitivity and/or numbness, increased skin rash with itching and heat).

Common(may affect up to 1 in 10 people):

Nausea

Headache

Dizziness

Fever

Itching

Rash

Redness of the skin

Abnormal liver function tests

Frequency not known(cannot be estimated from the available data): Hives (urticaria)

Tell your doctor immediately if you notice that the symptoms of the attack worsen after icatibant administration.

If you experience side effects, consult your doctor, even if they are not listed in this leaflet.

Reporting of side effects

If you experience any side effects, consult your doctor, pharmacist or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Icatibant Aguettant

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Do not use this medicine if you notice that the syringe or needle packaging is damaged or if you notice any visible signs of deterioration, such as the solution being cloudy, containing floating particles or having changed color.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of Icatibant Aguettant

The active substance is icatibant. Each pre-filled syringe contains 30 milligrams of icatibant (as acetate). The other ingredients are sodium chloride, glacial acetic acid and sodium hydroxide (for pH adjustment) and water for injections.

A

Icatibant Aguettant is presented as a clear and colorless solution for injection in a 3 ml glass pre-filled syringe.

The pack contains a hypodermic needle.

Icatibant Aguettant is available in a single pack of one pre-filled syringe with one needle or in a multipack of three pre-filled syringes with three needles.

Not all pack sizes may be marketed.

T

Laboratoire Aguettant

1 rue Alexander Fleming

69007 Lyon

France

Manufacturer responsible

Wessling GmbH

Johann-Krane-Weg 42,

48149 Münster,

Germany

F

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Country of registration
Spain
Active substance
icatibant
Prescription required
Yes
Manufacturer
Laboratoire Aguettant
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Alternatives to ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG
FIRAZYR 30 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
Dosage form: INJECTABLE, 30 mg
Active substance: icatibant
Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
Prescription required
ICATIBANT ACCORD 30 mg Injectable Solution in Pre-filled Syringe
Dosage form: INJECTABLE, 30 mg
Active substance: icatibant
Manufacturer: Accord Healthcare S.L.U.
Prescription required
ICATIBANTO CIPLA 30 mg Injectable Solution in Pre-filled Syringe
Dosage form: INJECTABLE, 30 mg
Active substance: icatibant
Manufacturer: Cipla Europe
Prescription required

Alternatives to ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG in Poland

Icatibant Universal Farma

Dosage form: Solution, 30 mg

Active substance: icatibant

Manufacturer: Universal Farma, S.L.

Prescription required

Ikatibant Ranbaxi

Dosage form: Solution, 30 mg

Active substance: icatibant

Manufacturer: Eurofins Proxy Laboratories BV Pharmadox Healthcare Ltd. Terapia S.A.

Prescription not required

Icatibant Fresenius

Dosage form: Solution, 30 mg

Active substance: icatibant

Manufacturer: Fresenius Kabi Austria GmbH

Prescription required

Icatibant Zentiva

Dosage form: Solution, 30 mg

Active substance: icatibant

Manufacturer: Eurofins Proxy Laboratories BV Pharmadox Healthcare Ltd.

Prescription required

Icatibant Medical Vallei

Dosage form: Solution, 30 mg

Active substance: icatibant

Manufacturer: Universal Farma, S.L.

Prescription required

Alternative to ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG in Ukraine

IKATIBANT-VISTA

Dosage form: solution, 30mg/3ml

Active substance: icatibant

Manufacturer: Nang Kuang Farmas'utikal Ko., Ltd.

Prescription required

Online doctors for ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ICATIBANTO AGUETTANT 30 mg Injectable Solution in Pre-filled Syringe EFG – subject to medical assessment and local rules.

5.0(3)

Ngozi Precious Okwuosa

General medicine6 years of experience

Key areas of consultation:

Preventive and family medicine
Women’s health, including gynaecology and obstetrics
Chronic disease management: hypertension, diabetes, and more
Mental health support, anxiety, and counselling
Postoperative care and lab test interpretation

Book a video appointment

Tomasz Grzelewski

Dermatology21 years of experience

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Book a video appointment

Tarek Agami

General medicine11 years of experience

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
Evaluation of symptoms and guidance on further diagnostic testing
Preventive check-ups and regular health monitoring
Medical support during travel or after relocation
Treatment adjustments and lifestyle recommendations based on your personal history

Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Book a video appointment

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

fever, chills, fatigue and viral symptoms
cough, sore throat, nasal congestion, breathing discomfort
bronchitis and mild asthma flare-ups
nausea, diarrhoea, abdominal pain, digestive infections
rashes, allergic reactions, redness, insect bites
muscle or joint pain, mild injuries, sprains
headache, dizziness, migraine symptoms
stress-related symptoms, sleep disturbances
questions about test results and treatment plans
management of chronic conditions in stable phases

Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

Advanced Trauma Life Support (ATLS)
Basic and Advanced Cardiac Life Support (BLS/ACLS)
Pediatric Advanced Life Support (PALS)
Prehospital Trauma Life Support (PHTLS)
eFAST and critical care transthoracic echocardiography
aviation medicine

He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.

Book a video appointment

Nuno Tavares Lopes

Family medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
Family medicine: hypertension, diabetes, cholesterol, chronic disease management
Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
Weight management and wellness: personalised weight loss programmes, lifestyle guidance
Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
Pain management: acute and chronic pain, post-surgical care
Public health: prevention, health screenings, long-term monitoring
Sick leave (Baixa médica) connected to Segurança Social in Portugal
IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment

Roman Raevskii

General medicine7 years of experience

Dr. Roman Raevskii is a licensed general practitioner in Spain, offering online medical consultations with a strong focus on prevention, early diagnosis, and personalized care. He combines evidence-based clinical expertise with a patient-centered approach to deliver comprehensive support.

Dr. Raevskii provides medical care in the following areas:

Diagnosis and management of common conditions: hypertension, diabetes, respiratory and digestive disorders.
Oncological consultations: early cancer detection, risk evaluation, and treatment navigation.
Supportive care for oncology patients – pain control, symptom relief, and side effect management.
Preventive medicine and health screenings.
Development of tailored treatment plans based on clinical guidelines.

With a patient-centred approach, Dr. Raevskii helps individuals manage both chronic illnesses and complex oncological cases. His consultations are guided by current medical standards and adapted to each patient’s needs.

Book a video appointment

Duarte Meneses

Family medicine5 years of experience

Dr. Duarte Meneses is a licensed family medicine and general practice doctor based in Portugal, with additional expertise in occupational health. He provides online consultations for adults, offering medical support for both acute symptoms and chronic health conditions.

Common symptoms such as fever, sore throat, cough, fatigue, or digestive issues
Chronic conditions including hypertension, diabetes, high cholesterol, and thyroid problems
Mental health concerns such as stress, sleep issues, anxiety, and burnout
Preventive care: health check-ups, lifestyle advice, and follow-up for existing conditions
Work-related health questions, sick leave documentation, and medical guidance for returning to work

Dr. Meneses graduated from the University of Beira Interior and has years of experience working with diverse patient populations. He is fluent in Portuguese, English, Spanish, and French.

His approach is friendly, clear, and focused on delivering practical medical advice tailored to each patient’s needs.

Book a video appointment

Sergio Correa

General medicine8 years of experience

Dr. Sergio Correa is a licensed general practitioner, aesthetic medicine specialist, and trichologist with experience in emergency care and preventive health. He offers online consultations in English and Spanish, supporting adult patients with a wide range of medical concerns – from acute symptoms to chronic condition management.

His areas of focus include:

General and urgent care: fever, fatigue, infections, digestive issues, respiratory symptoms, and other common concerns
Chronic condition support: hypertension, high cholesterol, diabetes, thyroid issues
Aesthetic medicine and dermatology: acne, skin ageing, hyperpigmentation, personalised skincare guidance
Trichology: hair loss, scalp conditions, treatment strategies for men and women
Preventive care: health check-ups, lifestyle advice, second opinions

Dr. Correa combines medical knowledge with an aesthetic and holistic approach to help patients improve both health and quality of life.

Book a video appointment

Svetlana Kovalenko

Family medicine15 years of experience

Dr Svetlana Kovalenko is a family medicine doctor with over 14 years of experience and a medical degree from Kharkiv National Medical University. She offers online consultations for adults, supporting patients with both acute and chronic conditions, preventive care, and personalised medical advice.

What patients commonly consult her for:

High blood pressure, type 2 diabetes, cholesterol management
Cold and flu symptoms: fever, cough, sore throat
Fatigue, sleep problems, headaches, general discomfort
Ongoing care for chronic conditions and medication review
Help interpreting test results and lab reports
Preventive check-ups and advice on healthy lifestyle habits

Dr Kovalenko combines evidence-based practice with a respectful, patient-centred approach. She takes time to explain, listens attentively, and helps each person make confident, informed decisions about their health.

Book a video appointment

Tetiana Fedoryshyn

General medicine30 years of experience

Dr Tetiana Fedoryshyn is a senior general practitioner, certified nutritionist, and psychologist with over 29 years of clinical experience. She combines classical internal medicine with modern approaches in lifestyle medicine, functional nutrition, and emotional health support.

Her focus is on helping patients regain health through deep understanding of symptoms, personalised nutrition plans, and evidence-based correction of deficiencies, stress-related conditions, and metabolic imbalances. Dr Fedoryshyn works with adults experiencing chronic conditions, fatigue, hormonal disruption, and post-stress exhaustion.

She integrates medical analysis, psychological insight, and real-life behaviour change tools to offer treatment plans tailored to each patient’s biochemistry, mental state, and lifestyle.

Main areas of practice: